Zevra Therapeutics, Inc. ZVRA Investment Proceeds
Investment Proceeds at other companies
Other financials
Where this comes from
Reported directly by Zevra Therapeutics, Inc. in its filing.
Tagged under the XBRL concept us-gaap:ProceedsFromSaleMaturityAndCollectionsOfInvestments.
The official record: Zevra Therapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →
Ask your AI about Zevra Therapeutics, Inc.'s investment proceeds.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Zevra Therapeutics, Inc.'s investment proceeds?
- Zevra Therapeutics, Inc. (ZVRA) reported investment proceeds of $93.97M in Q1 2026.
- How has Zevra Therapeutics, Inc.'s investment proceeds changed year-over-year?
- Zevra Therapeutics, Inc.'s investment proceeds increased by 422.1% year-over-year, from $18M to $93.97M.
- What does investment proceeds mean?
- Cash received from sales, maturities, and redemptions of investment securities across all categories.